Search bioRxivSearch

bioRxiv · 10.1101/346114

Learning the payoffs and costs of actions

Abstract

A set of sub-cortical nuclei called basal ganglia is critical for learning the values of actions. The basal ganglia include two pathways, which have been associated with approach and avoid behavior respectively, and are differentially modulated by dopamine projections from the midbrain. According to the influential opponent actor learning model, these pathways represent learned estimates of the positive and negative consequences (payoffs and costs) of actions. The level of dopamine release controls to what extent payoffs and costs enter the overall evaluation of actions. How the knowledge about payoff and cost is acquired is still an open question, even though many theories describe learning from feedback in the basal ganglia. We examine whether a set of plasticity rules proposed to model reinforcement learning in the pathways of the basal ganglia is suitable to extract payoffs and costs from a reward prediction error signal. First, we determine the result of such learning, both analytically and via simulations, for different reward schedules that feature payoffs and costs. Then, we combine the plasticity rules with a decision rule to examine the emerging effect of dopaminergic modulation on the willingness to work for reward. We find that the plasticity rules are suitable to infer the mean payoffs and costs of actions, if those occur at different moments in time. Successful learning requires differential effects of positive and negative reward prediction errors on the two pathways, and a weak decay of synaptic weights over trials. We also confirm that dopaminergic modulation produces effects on the willingness to work for reward similar to those observed in classical experiments.\n\nAuthor summaryThe basal ganglia are structures underneath the surface of the vertebrate brain, associated with error driven learning. Much is known about the anatomical and biological features of the basal ganglia; scientists now try to understand the algorithms implemented by these structures. Numerous models aspire to capture the learning functionality, but many of them only cover some specific aspect of the algorithm. Instead of further adding to that pool of partial models, we unify two existing ones - one which captures what the basal ganglia learns, and one that describes the learning mechanism itself. The first model suggests that the basal ganglia keeps track of both positive and negative consequences of frequent opportunities, and weighs these by the motivational state in decisions. It explains how payoff and cost are represented, but not how those representations arise. The other model consists of biologically plausible plasticity rules, which describe how learning takes place, but not how the brain makes use of what is learned. We show that the two theories are compatible. Together, they form a model of learning and decision making that integrates the motivational state as well as the learned payoffs and costs of opportunities.

Source connections

Explore related subjects

Keep this discovery

BibTeXRIS

Möller, M., Bogacz, R.. 2018-06-13. Learning the payoffs and costs of actions. https://doi.org/10.1101/346114

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

The Unreasonable Effectiveness of Cell Types in Describing Neuronal Physiological Features

Single-cell RNA sequencing (scRNA-seq) captures detailed gene expression profiles at scale, while patch-clamp recordings measure intrinsic neuronal electrophysiological properties. Modeling the relations between these two modalities remains a challenge. Here, we compare how well electrophysiological features can be predicted by traditional transcriptomic cell type classification, representations derived from a foundational model (scGPT) pretrained on large-scale scRNA-seq datasets, ion channel-coding genes, and highly variable genes. Using paired transcriptomic and electrophysiological patch-sequencing data from 495 human neurons from neurosurgical tissue, we find that cluster-level cell type representations consistently outperform highly variable gene selection, ion channel gene selection, and context-enriched scGPT embeddings. Notably, performance varies across model architectures and initializations, and the best results are obtained by combining the outputs of separate cell type and scGPT-based models. Together, these findings suggest that traditional discrete cellular classification is highly effective in predicting physiological features. For maximum performance it can be complemented by pretrained transformer models.

neuroscience

A nonlinear inhibition pathway underlying cortical responses to tuned holographic optogenetic perturbations

Optogenetics enables causal manipulation of cortical activity. Perturbation responses can be counterintuitive due to network interactions, making theory essential for predicting them. Existing approaches often rely on linear approximations, which fail for many biologically relevant perturbations. Here we develop a nonlinear theory of responses to holographic perturbations in cell-type-specific recurrent networks with structured connectivity. We fit a nonlinear model to mouse V1 data, which shows cotuned-ensemble suppression: perturbing spatially clustered neurons with similar preferred orientations yields markedly stronger short-range suppression than perturbing untuned ensembles. We show that cotuned-ensemble suppression arises from a feature-tuned, nonlinear inhibition pathway implicating somatostatin-positive (SST) interneurons. The theory predicts that cotuned ensembles suppress parvalbumin-positive (PV) neurons but facilitate SST neurons, and links the degree of cotuned-ensemble suppression or facilitation to the variance of the SST response. This framework identifies mechanisms by which nonlinear inhibition sculpts cortical dynamics and establishes a predictive basis for targeted optogenetic interventions.

neuroscience

Proteomic signatures of APOE ε4 across human tissues and cell types in Alzheimers disease

The apolipoprotein E {varepsilon}4 (APOE {varepsilon}4) allele is the strongest genetic risk factor for late-onset Alzheimers disease (AD). However, the underlying molecular mechanisms remain unclear. This study included 1691 participants from the Religious Orders Study and Rush Memory and Aging Project (ROSMAP), 1226 participants from the Accelerating Medicines Partnership - Alzheimers Disease (AMP-AD) Diverse Cohorts Study, and 735 participants from the Alzheimers Disease Neuroimaging Initiative (ADNI). To characterise APOE {varepsilon}4 molecular effects, we analysed proteomic data from plasma, cerebrospinal fluid (CSF), and induced pluripotent stem cell (iPSC)-derived astrocytes and neurons, as well as transcriptomic and proteomic data from multiple brain regions. The association of APOE {varepsilon}4 with AD neuropathology was also examined. APOE {varepsilon}4 carriers shared a plasma proteomic signature enriched for immune processes, irrespective of AD diagnosis. A machine learning classifier trained on this signature discriminated APOE {varepsilon}4 carriers from non-carriers in an independent cohort using CSF proteomics. APOE {varepsilon}4 carriage was associated with higher Braak stages and Consortium to Establish a Registry for Alzheimers Disease (CERAD) score. However, only limited APOE {varepsilon}4-associated transcriptomic and proteomic changes were observed in bulk brain tissue, with poor cross-layer concordance. Proteomic analyses of iPSC-derived astrocytes and neurons further revealed cell-type-specific APOE {varepsilon}4-associated changes. APOE {varepsilon}4 is associated with a consistent proteomic signature across plasma and CSF. Its molecular effects in the brain differ across cell types, brain regions and molecular layers. These findings support the need for cell-type-resolved multi-omic studies to elucidate how APOE {varepsilon}4 confers AD risk.

neuroscience